Daniel Nelson
@DWNelsonHPB
Followers
1K
Following
7K
Media
57
Statuses
1K
Surgical Oncologist | Associate Professor @utchattsurgery | U.S. Army Veteran | Contributor @BehindTheKnife
Chattanooga, TN
Joined May 2013
One of the coolest resources in surgical education! Strongly recommend checking it out.
CHRISTMAS CAME EARLY! In addition to general surgery, we now have colorectal, surgical oncology, and vascular surgery board simulators 🔥 ➡️➡️➡️ https://t.co/vpkrWYb3Jh Note, these are beta versions. Our full interface is being built now. We are pumped.
0
1
9
🎁'Tis the season🎄 Your 2⃣0⃣2⃣5⃣ HPB Wrapped is about to hit #SurgOncToday podcast!🎙️ 2⃣parts • 🔟 top studies • 4⃣guests • infinite HPB data 🫳🏻 dropping December 17 & 18
0
8
21
Our board simulator is absolutely rocking! 🔥 https://t.co/vpkrWYb3Jh🔥 Beta v2.6 features: ✔️ Extremely high-fidelity audio-audio examiner, scenarios available 24/7. ✔️ Exquisitely detailed, actionable feedback with recommended resources for study (this is so good) ✔️ Wingman
1
4
13
Is minimally invasive (robot) #Whipple surgery just as safe as open surgery? Today: #DIPLOMA2 RCT in @NEJMEvidence ➡️ https://t.co/amrQ7hTk4O 288 patients, 14 expert centers, 6 countries 🇳🇱🇮🇹🇩🇪🇧🇪🇪🇸🇸🇪): MIS equally safe as open in experienced centers. With faster recovery,
5
50
118
October Issue: Real-World Single-Center Experience with Neoadjuvant Gemcitabine, Cisplatin, and Durvalumab in Borderline Resectable #Cholangiocarcinoma @Yawwenyy @vanjapod
https://t.co/0fynkRjU2s
@CamilleLStewart
@SyedAAhmad5
0
9
14
Surgical Oncology Oral Boards are right around the corner. Check out this example scenario, which covers ADRENAL MASSES: 🎧 https://t.co/CcSMcfBP6q🎧 Surg Onc Oral Board Audio Review: https://t.co/NyzWKrINew
@DWNelsonHPB @BinghamMd
0
4
14
Looking for some easy listening on your Sunday? Check out our last 3 episodes: ✔️ Journal Review in Bariatric Surgery: Are Less Anastomoses Better? @docmartin22
@DrAdrianDan @CJMannMD ✔️ Are we failing our patients? Ventral hernia recurrence with @THeniford @MikeRosenMD ✔️
0
4
14
🚨 NEW EPISODE ALERT 🚨 Whatcha know about circulating tumor DNA? Take a listen and get educated! Join @MDAndersonNews @anishjayjain @timnewhook19 @VautheyMD for a robust discussion. 🎧 https://t.co/czVGCHUu4h 🎧
0
10
26
🩺🩺#ECGPulseCheck 🔎🔎 Should pts w/resectable high-risk iCCA (>5cm, node+, CA19-9, vascular invasion) be offered neoadjuvant therapy? @HalletJulie @curecc @AnnSurgOncol @HopSTranCao @FlavioRochaMD @skmaithel @SyedAAhmad5 @VautheyMD @BasGrootKoerkam @Seanpcleary @JavleMilind
5
4
17
Congrats to all the newly certified @AmBdSurg @SocSurgOnc Complex General Surgical Oncologists out there!!!
Surgical oncology oral boards are in February - no better time to start preparing than now! Our Surgical Oncology Oral Board Audio Review includes 46 high-yield scenarios that cover all of the SCORE CGSO topics designed for Surgical Oncology Surgeons by Surgical Oncology
1
0
13
The #Surgery community lost a GREAT one today. Dr. Eric Johnson - surgeon, friend, soldier, combat veteran, husband, father, skydiver, base jumper, leader, educator, and so much more. RIP my friend, I miss you already. Keep on "slingin that hash"! @AmCollSurgeons
18
22
134
#AudioVisualAbstract : Impact of Adherence to #OperativeStandards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic #Pancreatic #Adenocarcinoma @HollySpitz13 @WBAMCArmyMed
https://t.co/vVxgvSqePY
1
5
18
@BinghamMd @DWNelsonHPB and the rest of the crew hit it out of the park with these scenarios.
Surgical oncology oral boards are in February - no better time to start preparing than now! Our Surgical Oncology Oral Board Audio Review includes 46 high-yield scenarios that cover all of the SCORE CGSO topics designed for Surgical Oncology Surgeons by Surgical Oncology
0
2
6
Recalibrating Drain Fluid Amylase Cutoffs for Safer Early Removal and Fewer Complications after Pancreatoduodenectomy by Boyev A, Azimuddin A (...) Tzeng CD et 11 al. in J Gastrointest Surg https://t.co/z0crAK6Hdr
2
8
17
Kudos to Hauke Lang & Jens Mittler for a fabulous #EWALT2023 in Mainz 🇩🇪 Excellent talks #liver #biliary by leaders and rising stars 👏 Fabulous presentation on evaluation and treatment of Klatskin tumors today! Looking forward to #EWALT2025 in Milan 🇮🇹 @SSATNews @hpb_so
1
8
52
Expert lecture by @timnewhook19 on ctDNA-driven clinical decision-making for colorectal liver mets. Full auditorium at https://t.co/QC7ZEHxidd in Mainz. @MDAndersonNews #oncsurgery @AHPBA @IHPBA @SSATNews @JSHBPS @SocSurgOnc @EAHPBA
0
7
62
🔥💯 masterclass on future surgical perspectives for pts w/iCCA from @HopSTranCao at #EWALT2023 Inspiring leader in the fight against #cholangiocarcinoma
@MDAndersonNews @VautheyMD @ccadigest @JavleMilind @curecc @CDTzeng #oncsurgery
0
10
25
Who needs hypertrophy? When?PVE or LVD? Great talk by @VautheyMD -Studies w/PVE vs LVD had insufficient PVE! (Low KGR) -sFLR<19% consider LVD -Y90 evaluated as option for contralateral hypertrophy while “treating” ipsilateral dz @CDTzeng @HopSTranCao @SSATNews #EWALT2023
0
6
22
INTRODUCING: Surgical Oncology Oral Board Audio Review. 46 high-yield scenarios covering all SCORE CGSO topics. Listen to full scenario 👇🏼 https://t.co/zSXUhSaOb1 By surgical oncologists, for surgical oncologists! @BinghamMd @DWNelsonHPB @michaelyehmd
@JamesWuMD @mdAlvaradoMD
2
5
34
Failure to receive both standard-adherent surgery and guideline-recommended treatments was independently associated with a 78% increased risk of death (HR 1.78; CI 1.70-1.86; p<0.001). @AnnSurgOncol @McMastersKelly
Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic Pancreatic Adenocarcinoma @AnnSurgOncol @DWNelsonHPB @mkatzmd
0
1
3